Related by context. All words. (Click for frequent words.) 81 DIABECELL R 71 DiabeCell R 70 DiabeCell ® 70 DIABECELL 64 BioSTAR R 63 Certican 62 DiabeCell 62 STRIDE PD 62 riociguat 62 prasterone 62 intradermal injection 62 GTC recombinant human 62 omega interferon 62 trastuzumab Herceptin ® 62 budesonide foam 61 hepatic arterial 61 Degarelix 61 recombinant FSH 61 pain palliation 61 Cellegesic 61 HDL Selective Delipidation 61 BrachySil TM 60 stem cell transplantations 60 cinacalcet 60 SIR Spheres microspheres 60 Vascugel 60 GAMMAGARD 60 SIR Spheres 60 relapsing remitting MS RRMS 60 VIR# 60 allogeneic HSCT 60 novel VDA molecule 60 subcutaneous immunoglobulin 60 NAVISTAR R 60 CardioPass TM 60 Neo Bladder Augment 60 GnRH agonists 60 intravenous immunoglobulin 60 Gonal f 59 Mimpara 59 postoperative chemotherapy 59 INTERCEPT platelets 59 Rheos System 59 MitraClip device 59 Islet transplantation 59 CTAP# Capsules 59 Alvesco R 59 urinary N telopeptide 59 Accelerated Partial Breast Irradiation 59 Natalizumab 59 immunosuppression therapy 59 Arranon 59 carotid artery stenting 59 Sanvar R 59 docetaxel Taxotere ® 59 everolimus eluting stents 59 teduglutide 59 Phase IIIb study 59 TEMODAL 59 HepaSphere 59 Nivestim 59 Telatinib 59 recombinant factor VIIa 59 MAGE A3 ASCI 59 RoACTEMRA 59 systemic hypotension 59 Mimpara R 59 lenalidomide dexamethasone 59 ORMD 59 adipose derived stem cell 59 PSMA ADC 59 aromatase inhibitor therapy 59 haematopoietic stem cell 59 PROMUS Element Stent 59 Cumulase 59 GnRH agonist 59 Phase IIb III 59 rhLF 59 therapeutic regimens 59 percutaneous drainage 59 LHRH receptor positive 59 CVac 59 acetonide FA 58 intradermal injections 58 multicenter Phase II 58 Reclast Aclasta 58 dosage regimens 58 YONDELIS 58 aerosolized KL4 surfactant 58 POSIDUR TM 58 mertansine 58 Kepivance 58 Fludara ® 58 systemic immunosuppressive drugs 58 Phase IIIb clinical 58 Ozurdex 58 liver resection surgeries 58 renal biopsy 58 Granulocyte Colony Stimulating Factor 58 BEXXAR 58 oral deforolimus 58 opioid analgesia 58 chronic myocardial ischemia 58 AZILECT ® 58 myoblast therapy 58 APTIVUS 58 Androxal TM 58 Intra arterial 58 sacral nerve stimulation 58 Noxafil 58 Certolizumab pegol 58 transarterial 58 Gamunex C 58 HepDirect prodrug 58 A1PI 58 pulmonary artery banding 58 Plenaxis TM 58 ABSORB trial 58 Zavesca r 58 COMFORT II 58 AngioJet thrombectomy 58 Helicobacter pylori eradication 58 trastuzumab DM1 58 Thalidomide Pharmion 58 PRIMO CABG 58 IL# PE#QQR 58 cytotoxic therapy 58 renal denervation 58 peak plasma concentrations 58 corifollitropin alfa 58 intestinal mucosal 58 intravenous cyclophosphamide 58 CINTREDEKIN BESUDOTOX 58 ganaxolone 58 mTOR inhibition 58 VitroGro 58 antiangiogenic therapy 58 Increlex R 58 trastuzumab DM1 T DM1 58 EXJADE 58 Endovascular Graft 58 TASKi3 58 Lofexidine 58 risk reducing salpingo 58 Egrifta 58 Vascugel ® 58 NATRECOR ® 58 VivaGel ™ 58 weekly subcutaneous injections 58 SEPET TM 57 intravenous immunoglobulin IVIG 57 Dacogen decitabine 57 OsseoFix 57 pharmacokinetic characteristics 57 Allovectin 7 ® 57 IGF 1R inhibitor 57 CONBRIZA 57 intravenous iv 57 dirucotide MBP# 57 macrolide antibiotic 57 antiplatelet medications 57 rFVIIa 57 inhaled iloprost 57 acyclovir Lauriad R 57 eTag assays 57 BNC# 57 demonstrated antitumor activity 57 refractory prostate cancer 57 oral anticoagulant therapy 57 Lucrin 57 PrevOnco ™ 57 Multiferon R 57 Pemetrexed 57 HuMax EGFr 57 Soliris eculizumab 57 exocrine pancreatic insufficiency EPI 57 Capesaris 57 colonoscopic 57 thoracic aortic aneurysms 57 CellCept mycophenolate mofetil 57 thromboprophylaxis 57 Hepatocellular Carcinoma HCC 57 oral methylnaltrexone 57 RSD# oral 57 Cook Zenith TX2 57 urocortin 2 57 methylnaltrexone bromide 57 coronary stenting 57 Diamyd r 57 Privigen 57 Mycophenolate Mofetil 57 Gliadel Wafer 57 adult chronic ITP 57 eSVS MESH 57 dual endothelin receptor antagonist 57 neurocognitive outcomes 57 invasive candidiasis 57 relapsed MM 57 pancreatic insufficiency 57 thorough QT 57 unresectable tumors 57 Proellex TM 57 Ampligen ® 57 liposomal formulation 57 vinorelbine tartrate 57 Xelox 57 SNT MC# 57 intravenous tPA 57 epoetin alpha 57 UPLYSO 57 cranial radiation 57 liver resection 57 NEBIDO 57 somatostatin analog 57 SPRIX ® 57 convenient dosing regimens 57 GeoVax vaccine 57 Raptiva R 57 BEXXAR Therapeutic Regimen 57 bladder augmentation 57 Femara letrozole 57 Biopump 57 ® lenalidomide 57 allogeneic hematopoietic cell 57 CardioPass 57 Glufast 57 ACTEMRA TM 57 autologous SCT 57 Rasilez HCT 57 bovine thrombin 57 ACV1 57 BeneFIX 57 blood clot dissolver 57 recurrent glioma 57 QuadraSphere 57 PhG alpha 1 57 AST ALT 57 haematologic 57 Factor VIIa 57 Edwards SAPIEN valve 57 Non inferiority 57 recurrent malignant glioma 57 multicenter clinical trials 57 lomitapide 57 Phase III ADT 57 Tacrolimus 57 SCENESSE ® 57 BST CarGel R 57 LEUKINE 57 Prodarsan 57 certolizumab 57 ATACAND 57 Somatuline Depot 57 doxorubicin docetaxel 57 preclinical efficacy 57 afamelanotide 57 HuMax TAC 57 Phase IIb clinical trials 57 Lymph node 57 diaphragm pacing 57 INVO procedure 57 Prodarsan ® 57 miglustat 57 Surgical Ablation System 57 Increlex ® 56 BrachySil ™ 56 viral kinetics 56 Sutent sunitinib 56 Ventavis ® 56 clevidipine 56 VITOSS 56 Achieves Primary Endpoint 56 OvaRex ® MAb 56 Bendamustine 56 ARIKACE ™ 56 Phase Ib II 56 IOP lowering 56 HIFU tumor 56 mecasermin 56 somatostatin analogues 56 autologous transplants 56 SCIg 56 vidofludimus 56 Elocalcitol 56 Aclasta Reclast 56 cediranib 56 ToGA 56 Hexvix ® 56 methylnaltrexone 56 calcineurin inhibitor 56 paclitaxel poliglumex 56 R0 resection 56 renal transplants 56 phase IIb study 56 engineered urethras 56 injectable formulations 56 intracavitary 56 artery embolization 56 NSABP B 56 palliative radiotherapy 56 Plicera 56 thromboembolic disease 56 Metricath Gemini 56 PREOS 56 MYDICAR ® 56 Rasagiline 56 intravenous AAT 56 saline placebo 56 ADAGIO study 56 virological response 56 rFactor XIII 56 prospectively stratified 56 clinical pharmacology studies 56 successfully commercialize Iluvien 56 AFRS TM 56 olanzapine LAI 56 biliary tract cancer 56 ritonavir boosted 56 gadobutrol 56 Thelin tm 56 Octreolin 56 VentrAssist 56 TheraCIM h R3 56 Remune 56 dalteparin 56 FXIII 56 bone grafting procedures 56 OHR/AVR# 56 CardioFit 56 OncoGel 56 buccal spray 56 Tavocept 56 multicenter trials 56 MYDICAR 56 Fingolimod 56 imexon 56 PRESEPT study 56 vascular insufficiency 56 hoFH 56 Subgroup analyzes 56 undetectable HBV DNA 56 alpha1 antitrypsin deficiency 56 PET tracers 56 lenalidomide Revlimid R 56 ReN# 56 thromboembolic complications 56 NLX P# 56 serum lipid 56 Aryplase 56 MitraClip R 56 Pivotal Clinical Trial 56 Cardiopulmonary bypass 56 oral rivaroxaban 56 Plasmin 56 atherosclerotic renal artery stenosis 56 Aridol TM 56 drug ISA# 56 Trofex 56 GLASSIA 56 CIMZIA TM 56 percutaneous transluminal coronary angioplasty 56 Anti Bacterial Envelope 56 LVAS 56 terlipressin 56 TORISEL 56 adjuvant cisplatin 56 GORE TAG Device 56 PHX# 56 HER2 expression 56 CCR5 mAb 56 radioiodine therapy 56 esophageal gastric 56 Belerofon 56 HepaSphere Microspheres 56 metastatic gastric 56 vapreotide acetate 56 eculizumab therapy 56 endocrine therapies 56 TRO# 56 neurologic outcomes 56 lanthanum carbonate 56 treprostinil 56 pharmacodynamic PD 56 malignant ascites 56 refractory angina 56 rufinamide 56 smoldering multiple myeloma 56 Tectin TM 56 oral prodrug 56 MAXY alpha 56 Thrombin 56 regulator Medsafe 56 ZOLINZA 56 Onko Sure TM 56 autologous chondrocyte implantation 56 molecular diagnostic assay 56 Cx# [002] 56 sitaxsentan 56 AMPK activators 56 DCVax Brain 56 ano genital warts 56 hemostatic efficacy 56 pharmacokinetic equivalence 56 transplantation HCT 56 r hGH 56 TroVax ® 56 scintigraphic 56 lumbar spinal stenosis LSS 56 Thalomid ® 55 hematological parameters 55 antifungal therapy 55 phase IIb trial 55 ChronVac C 55 eprotirome 55 ancrod 55 euthyroid 55 stereotactic radiotherapy 55 STELARA ™ 55 pralidoxime 55 Insulin detemir 55 Trifecta valve 55 efalizumab 55 QVAR 55 uridine triacetate 55 CA9 SCAN 55 endometrial biopsy 55 topical testosterone 55 CBLC# 55 Coronary Artery Bypass Graft 55 cinacalcet HCl 55 HCV protease inhibitors 55 ELACYT 55 percutaneous vertebroplasty 55 Raptiva ® 55 MTWA testing 55 Advagraf 55 colesevelam HCl 55 hypervascular tumors 55 soft gelatin capsule 55 inhaled AAT 55 pretransplant 55 REMINYL ® 55 inecalcitol 55 gastrointestinal stromal tumors GISTs 55 GIPET 55 AGILECT R 55 gastrointestinal stromal tumors GIST 55 SUTENT ® 55 BrachySil 55 Lubiprostone 55 EchoCRT 55 LymphoStat B TM 55 Hectorol R 55 myelodysplastic myeloproliferative diseases 55 Surfaxin LS 55 bronchoscopic procedure 55 CIPN 55 Anadis 55 BioSTAR ® 55 NeuroSTAT ® 55 Pitavastatin 55 #mg ATC 55 Isolagen Process 55 metastatic malignant 55 orphan designation 55 OZURDEX ® 55 cysteamine bitartrate 55 intensive lipid lowering 55 Arikace 55 KRAS status 55 OnDose 55 Technosphere Insulin 55 idursulfase 55 metastatic bladder 55 DCCR 55 dose proportionality 55 IRESSA 55 WinRho R SDF 55 preclinically 55 hepatorenal syndrome 55 DCVax R Brain 55 Powerlink System 55 lung resection 55 Absorbable 55 edifoligide E2F Decoy 55 daily subcutaneous injections 55 Levacor TM 55 cardiovascular calcification 55 TriActiv R System 55 ATryn ® GTC recombinant 55 skin sterol 55 Myocet 55 d dimer 55 Initiate Clinical Trial 55 Dupuytren Contracture 55 drug eluting coronary stent 55 CELVAPAN H#N# 55 Vacc 4x 55 androgen deprivation 55 Basilea Toctino R 55 rhBMP 2 55 tumor necrosis 55 Civacir 55 serum calcium levels 55 induce ovulation 55 immunosuppressives 55 edifoligide 55 intracranial hemorrhage ICH 55 CINQUIL 55 aerosolized surfactant 55 Phase #b/#a clinical 55 Zorbtive TM 55 fibrotic disease 55 Monovisc 55 PROMACTA 55 acute HAE attacks 55 CytoSorb TM 55 dose escalation phase 55 e2 Collector 55 TM Drug Eluting 55 carotid endarterectomy CEA 55 renoprotective 55 Urocidin TM 55 Microwave Ablation System 55 Phase III Psoriasis 55 Campath alemtuzumab 55 MGN# 55 Selective Electrochemical Tumor Ablation 55 adjuvant radiation 55 phase IIb III 55 hMG 55 dyslipidaemia 55 bardoxolone 55 THALOMID 55 BioDisc 55 cerebral vasospasm 55 azilsartan medoxomil 55 infused intravenously 55 BoNTA 55 MitoQ 55 Toraymyxin 55 SEBIVO 55 ticagrelor Brilinta 55 CompuFlo 55 optimal dosing 55 Poly ICLC 55 Cancidas 55 Resolute DES 55 SCENESSE R 55 InterStim ® 55 Medidur FA 55 TH# [003] 55 pramlintide metreleptin combination 55 Augment Injectable 55 MastaScope 55 bioabsorbable stent 55 Européenne Mark 55 5-fluorouracil/leucovorin 55 stavudine d4T 55 benign prostatic hyperplasia enlarged 55 primary dysmenorrhoea 55 Bondronat 55 Zemplar Capsules 55 femoral neck fracture 55 CRMD# 55 Visian Toric ICL 55 GLP toxicology studies 55 Tibolone 55 nucleotide analogue 55 Coronary stents 55 Receives Marketing Authorization 55 thymectomy 55 Tesmilifene 55 interferon ribavirin 55 NeuroVax 55 inhaled treprostinil 55 p# biomarker 55 Zavesca 55 Allogeneic 55 Submits Response 55 benign prostatic hypertrophy 55 Roche Herceptin 55 BRAF V#E mutation 55 immunosuppressive regimen 55 MVA MUC1 IL2 55 aprepitant 55 ospemifene 55 STEEN Solution ™ 55 malignant neoplasms 55 PYY #-# 55 Carticel 55 immunotherapeutic vaccine 55 Cinquil 55 Intravitreal 55 verteporfin 55 ICH guidelines 55 chemoradiation therapy 55 cilengitide 55 multicenter randomized controlled 55 mesalazine 55 Keppra XR 55 alfa interferon 55 NeuroFlo 55 EDEMA3 trial 55 recurrent metastatic 55 ARIXTRA R 55 venous thromboembolism VTE prophylaxis 55 abacavir Ziagen 55 OvaRex MAb 55 subcutaneous methylnaltrexone 55 hsCRP levels 55 orally inhaled 55 pharmacodynamic properties 55 HDR brachytherapy 55 overactive bladder syndrome 55 pegylated interferon alfa 55 T1DM 55 Triapine R 55 thrombolytic agents 55 Onconase 55 dose escalation clinical 55 including eniluracil ADH 55 APTIVUS ritonavir 55 cerebral somatic oximeter 55 indibulin 55 oral talactoferrin 55 pharmacodynamic markers 55 TYZEKA 55 oxymorphone ER 55 chemoradiotherapy 55 Carotid endarterectomy 55 ColonSentry TM test 55 esophagogastric 55 perioperative morbidity 55 LC#m# 55 Angiox R 55 TELINTRA 55 transabdominal 55 trabectedin 55 ELIQUIS 55 angiographic outcomes 55 Temsirolimus 55 BCR ABL inhibitor 55 PROMUS TM 55 OrCel ® 55 peritoneal carcinomatosis 55 levocetirizine 55 mismatched bone marrow 55 immune modulatory 55 transapical approach 55 CYT# QbG# 55 serum biomarker 55 Oxaliplatin 55 RNAi therapeutic targeting PCSK9 54 Artelon ® 54 randomized multicenter trial 54 intravenous diuretics 54 Altera Nebulizer System 54 bortezomib Velcade 54 Renal Cell Carcinoma RCC 54 urethral bulking agent 54 pelvic lymphadenectomy 54 pancreatectomy 54 thrombotic complications 54 PNH patients 54 XIENCE V Everolimus Eluting 54 Dalbavancin 54 cervical cerclage 54 intranasal delivery 54 BLA filing 54 DEB# 54 Cleviprex TM clevidipine 54 direct thrombin inhibitor 54 immunosuppressive medications 54 Neovasc Reducer 54 Mipomersen 54 IDO inhibitor 54 knee osteoarthritis OA 54 CoreValve System 54 Argatroban 54 Cystectomy 54 Gattex 54 abnormal uterine bleeding 54 pharmacokinetic PK profile 54 Shonin approval 54 cervical lymph node 54 Fibrillex 54 gynecologic procedures 54 LungAlert TM 54 StemEx R 54 CCR5 inhibitor 54 viral inactivation 54 intermittent dosing 54 phase IIa 54 budesonide MMX Phase III 54 PHPT 54 NP2 Enkephalin 54 ClearPath HDR 54 oral anticoagulation 54 Liver transplantation 54 phase IIb clinical 54 Etanercept 54 ReN# therapy 54 Cardiorespiratory fitness 54 benign prostatic hypertrophy BPH 54 zotarolimus 54 ruxolitinib 54 PFO migraine 54 carotid revascularization 54 Torisel 54 artery stenosis 54 Preotact R 54 T1c 54 MIST II 54 Bacillus Calmette Guerin BCG 54 novel therapeutic antibodies 54 dosing cohort 54 alpha#beta# integrin 54 mesalamine granules 54 rBChE 54 FIRAZYR 54 SomatoKine 54 preclinical pharmacokinetic 54 sipuleucel T 54 liver transplant recipients 54 DASISION 54 glycated hemoglobin levels 54 Allovectin 7 54 trypsin digestion 54 beta lactam antibiotic 54 Radical prostatectomy 54 gepirone ER 54 TAXUS Element Stent System 54 DCVax ® Brain 54 Fully Covered Stent 54 AmpliChip 54 immunosuppressant drug 54 induce remission 54 prospective multicentre 54 Surgical excision 54 Twinrix 54 Elonva 54 Pivotal Trial 54 BETAS 54 REPEL CV 54 elacytarabine 54 PresbyLens ® 54 ATPace TM 54 Azilect ® 54 Phase III psoriasis 54 Endologix Powerlink System 54 Atypical Hemolytic Uremic Syndrome 54 coronary stent merged 54 randomized controlled clinical trials 54 antiarrhythmic drugs 54 REVLIMID lenalidomide 54 CALGB # [002] 54 insulin glulisine 54 DepoDur TM 54 isoflavone supplement 54 plasma pharmacokinetics 54 micronized progesterone 54 rALLy clinical trial 54 Nexavar sorafenib 54 OPCAB 54 hGH CTP 54 Phase III Clinical Trial 54 pharmacodynamic effects 54 PhotoCure 54 Centralized Procedure 54 Mepact 54 oral renin inhibitor 54 papillary renal cell carcinoma 54 K DOQI 54 vemurafenib 54 gynaecologic 54 AOD# [002] 54 TNF alpha inhibitor 54 ureteral stents 54 phase IIa clinical 54 CytoFabTM 54 WallFlex Biliary RX 54 OnDose TM 54 IMPACT DCM clinical 54 CryoValve SG 54 insulin analogs 54 IIa clinical trials 54 vitro pharmacology 54 colorectal cancer liver metastases 54 intravesical therapy 54 pitavastatin 54 PressureWire 54 histamine dihydrochloride 54 corticosteroid dexamethasone 54 VANOS TM 54 NV1FGF 54 CHAMPION PCI 54 CMV infections 54 aromatase inhibitors AIs 54 NeuVax 54 pegfilgrastim 54 VCUG 54 Loramyc R 54 Posidur 54 suppressive therapy 54 carotid IMT 54 intracerebral 54 CsA 54 peripheral vascular stent 54 Intravitreal injections 54 total thyroidectomy 54 leiomyomas 54 Immunosuppressant 54 Ophena 54 vecuronium 54 arsenic trioxide injection 54 apolipoproteins 54 Resolute stent 54 DURIN TM 54 Neurostep TM 54 tolperisone 54 antibiotic regimens 54 intramuscular injections 54 CLARITY study 54 SANVAR 54 debulking surgery 54 Neulasta R 54 Initiates Enrollment 54 rxRNA 54 pamidronate 54 wilate ® 54 salmeterol fluticasone 54 nonsmall cell lung cancer 54 Rapaflo 54 Dural Sealant 54 BPS IC 54 nasally delivered 54 thrombus aspiration 54 saphenous vein graft 54 pharmacokinetic PK study 54 tropism testing 54 BioDelivery Sciences Announces 54 superficial bladder cancer 54 serological tests 54 Pivotal Phase III 54 Perforomist ™ Inhalation Solution 54 Randomised controlled trials 54 androgen ablation 54 Striant 54 canakinumab 54 Transcatheter 54 OLYMPIA registry 54 mycophenolate mofetil MMF 54 GRNVAC1 54 prostate carcinoma 54 Kit CD# positive 54 neoadjuvant 54 standard chemotherapy regimen 54 pelvic ultrasound 54 aurora kinase 54 Japanese Encephalitis vaccine 54 Orphan Status 54 percutaneous catheter 54 Vivaglobin 54 adalimumab Humira 54 Antibiotic prophylaxis 54 Vernakalant 54 RRMS patients 54 TriGrid 54 selective modulator 54 symptomatic VTE 54 Lumiracoxib 54 alagebrium 54 β blockers 54 liver metastasis 54 Mylotarg 54 Embosphere Microspheres 54 Manja Bouman CEO 54 trastuzumab emtansine T DM1 54 malignant pleural mesothelioma 54 Cellcept 54 postexposure prophylaxis 54 GED aPC 54 adolescent idiopathic scoliosis 54 TAXUS Stents 54 RECOTHROM R 54 Glypromate 54 antioxidant supplementation 54 Vascular Wrap 54 Pagoclone 54 synthetic peptide containing 54 adjunctively 54 AGHD 54 chronic periodontitis 54 paracentesis 54 Plenaxis R 54 epithelial ovarian cancer 54 Hydroxyurea 54 Breast conserving 54 vivo validation 54 Hepatic 54 endothelin antagonists 54 ADAGEN 54 immunomodulatory agents 54 thymidine kinase 54 metastatic RCC 54 alemtuzumab MS 54 hypogonadal men 54 commercialize deforolimus 54 Personalized Immunotherapy 54 HeartNet 54 ER CHOP 54 Velcade bortezomib 54 osteolytic 54 Soliris TM eculizumab 54 Targretin capsules 54 romiplostim 54 Nonsurgical 54 PureGraft ™ 54 ovulatory cycles 54 Tracleer ® 54 oral PTH 54 antithrombotic therapy 54 Evoltra ® 54 CORTOSS 54 Combination antiretroviral therapy 54 Phase IIa trials 54 lymphomas leukemias 54 Prodarsan R 54 platelet inhibitor 54 chronic HBV 54 ImmuKnow R 54 CYPHER Stent 54 ONCONASE R 54 mutated K ras 54 dosimetric 54 cerebral angiography 54 radical cystectomy 54 conjugate vaccines 54 Vaxfectin TM 54 deferoxamine 54 Immunotherapeutic 54 HVAD 54 Phase 1a clinical 54 LLLT 54 TRIST study 54 de novo kidney transplant 54 PCA3 assay 54 midstage trials 54 pharmacodynamic parameters 53 Tasimelteon 53 transrectal ultrasound guided 53 patients undergoing CABG 53 calcaneal fractures 53 Completes Patient Enrollment 53 ThGRF 53 tumorigenicity 53 Rubicon Filter 53 Silodosin 53 trials RCTs 53 maximally tolerated dose 53 GORE TAG Thoracic Endoprosthesis 53 E2F Decoy 53 Emselex 53 NeoVisc ® 53 coronary revascularization procedures 53 BioMatrix TM 53 containing abacavir 53 Randomized controlled 53 GnRH analogue 53 Teysuno 53 reactogenicity 53 MAA submission 53 anti coagulant therapy 53 Phase #/#a 53 AERx iDMS 53 hyperuricaemia 53 transthyretin amyloidosis 53 ADVANCE PD 53 oral salmon calcitonin 53 Syncria 53 concomitant medications 53 thrombolytic agent 53 Progenta TM 53 liver histology 53 Phase Ib clinical 53 Intravenous immunoglobulin 53 Endometrial 53 serologic testing 53 Phe restricted diet 53 glomerular filtration 53 Adult Stem Cell Therapy 53 fosbretabulin 53 haematological cancers 53 external beam radiotherapy 53 Phase 2b kidney transplant 53 ATIR ™ 53 Zevalin consolidation 53 neratinib